Abstract:N-methyl-D-aspartate receptors (NMDARs emerging from GRIN genes) are tetrameric receptors that form diverse channel compositions in neurons, typically consisting of two GluN1 subunits combined with two GluN2(A-D) subunits. During prenatal stages, the predominant channels are di-heteromers with two GluN1 and two GluN2B subunits due to the high abundance of GluN2B subunits. Postnatally, the expression of GluN2A subunits increases, giving rise to additional subtypes, including GluN2A-containing di-heteromers and tri-heteromers with GluN1, GluN2A, and GluN2B subunits. The latter emerge as the major receptor subtype at mature synapses in the hippocampus. Despite extensive research on purely di-heteromeric receptors containing two identical GRIN variants, the impact of a single variant on the function of other channel forms, notably tri-heteromers, is lagging. In this study, we systematically investigated the effects of two de novo GRIN2B variants (G689C and G689S) in pure, mixed di- and tri-heteromers. Our findings reveal that incorporating a single variant in mixed di-heteromers or tri-heteromers exerts a dominant negative effect on glutamate potency, although 'mixed' channels show improved potency compared to pure variant-containing di-heteromers. We show that a single variant within a receptor complex does not impair the response of all receptor subtypes to the positive allosteric modulator pregnenolone-sulfate (PS), whereas spermine completely fails to potentiate tri-heteromers containing GluN2A and -2B-subunits. We examined PS on primary cultured hippocampal neurons transfected with the variants, and observed a positive impact over current amplitudes and synaptic activity. Together, our study supports previous observations showing that mixed di-heteromers exhibit improved glutamate potency and extend these findings towards the exploration of the effect of Loss-of-Function variants over tri-heteromers. Notably, we provide an initial and crucial demonstration of the beneficial effects of GRIN2B -relevant potentiators on tri-heteromers. Our results underscore the significance of studying how different variants affect distinct receptor subtypes, as these effects cannot be inferred solely from observations made on pure di-heteromers. Overall, this study contributes to ongoing efforts to understand the pathophysiology of GRINopathies and provides insights into potential treatment strategies.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is related to the research on the dysfunction of NMDA receptors (NMDARs), especially when there are loss - of - function (LoF) variants of the GRIN2B gene in these receptors. Specifically, the research focuses on how two new GRIN2B variants (G689C and G689S) affect the functions of pure di - heteromers, mixed di - heteromers and tri - heteromers NMDA receptors. In addition, the paper also evaluates the possibility of pregnenolone - sulfate (PS) as a potential therapeutic drug for the functional recovery of these variant receptors. ### Research Background NMDA receptors are ion channels composed of multiple subunits, mainly encoded by genes such as GRIN1, GRIN2A - D, GRIN3A - B. Functional NMDA receptors usually contain two essential GluN1 subunits and two GluN2 subunits. During development, the composition of NMDA receptors changes dynamically. In the fetal stage, di - heteromer receptors containing two GluN2B subunits are mainly expressed. After birth, the expression of GluN2A subunits increases, forming more receptor subtypes, including tri - heteromer receptors containing GluN1, GluN2A and GluN2B. ### Research Questions 1. **Effects of Variants on NMDA Receptor Function**: - Evaluate how the G689C and G689S variants in the GRIN2B gene affect the functions of pure di - heteromers, mixed di - heteromers and tri - heteromers NMDA receptors. - Pay special attention to the effects of these variants on glutamate potency. 2. **Drug Treatment Potential**: - Evaluate whether pregnenolone - sulfate (PS) can restore the functions of variant NMDA receptors. - Compare the enhancing effects of PS on different types of NMDA receptors (pure di - heteromers, mixed di - heteromers and tri - heteromers). ### Main Findings - **Effects of Variants**: - A single GRIN2B variant (G689C or G689S) causes a significant decrease in glutamate affinity in mixed di - heteromers and tri - heteromers, but the effect is not as severe as that of the variant in pure di - heteromers. - Mixed di - heteromers show better glutamate affinity than pure di - heteromers. - **Drug Treatment**: - Pregnenolone - sulfate (PS) can partially restore the functions of variant NMDA receptors, especially most obviously in pure di - heteromers. - PS has a certain enhancing effect on all types of NMDA receptors, but the enhancing effect on tri - heteromers is relatively weak. ### Conclusion This study emphasizes the effects of different variants on the functions of NMDA receptor subtypes and provides preliminary evidence of pregnenolone - sulfate (PS) as a potential therapeutic drug. These findings are helpful for understanding the neuropathological mechanisms caused by GRIN gene variants and provide new ideas for developing treatment strategies.

Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants

Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders

Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors

GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms

Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids

N-terminal alternative splicing of GluN1 regulates the maturation of excitatory synapses and seizure susceptibility.

Presynaptic hyperexcitability reversed by positive allosteric modulation of a GABABR epilepsy variant

Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology

Heterogeneous Clinical and Functional Features of GRIN2D-related Developmental and Epileptic Encephalopathy.

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor

The Effects of NMDA Subunit Composition on Calcium Influx and Spike Timing-Dependent Plasticity in Striatal Medium Spiny Neurons

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

De Novo Mutations and Rare Variants Occurring in NMDA Receptors.

Disease-associated missense mutations in GluN2B subunit alter NMDA receptor ligand binding and ion channel properties

Selective Cell-Surface Expression of Triheteromeric NMDA Receptors

Clinical and functional consequences of GRIA variants in patients with neurological diseases

Radiprodil, a selective GluN2B negative allosteric modulator, rescues audiogenic seizures in mice carrying the GluN2A(N615S) mutation

GRIN2B disease-associated mutations disrupt the function of BK channels and NMDA receptor signalling nanodomains

Recurrent seizure‐related GRIN1 variant: Molecular mechanism and targeted therapy

Relationship between availability of NMDA receptor subunits and their expression at the synapse